Bioventus® is a global leader in orthobiologics and its mission is to make a difference by helping patients resume and enjoy active lives. Bioventus accomplishes this with its orthobiologic solutions for musculoskeletal healing and regeneration that engage and enhance the body’s healing process.

The company has products for bone healing, bone graft and knee osteoarthritis. Established in 2012, Bioventus is privately held and headquartered in Durham, NC. The company has more than 700 employees worldwide and its international headquarters is in Hoofddorp, The Netherlands.

Bioventus also has offices in Memphis, TN and Toronto, Ontario, Canada. Bioventus works with patients, payers and health care providers throughout the world, and generates $300 million dollars in yearly revenue.

Manufacturing

Medical Devices

Pharmaceutical

Bioventus

Robert Claypoole

Katrina Pope

Tim Donovan

Tony D’Adamio

Rachel W.

Paula Hattley

Miguel O. Beltrán-Delgado

Mark Singleton

Keith McBride

John Nosenzo

Cindy Brammer

Averi Parris

Anthony Doyle

Andrew Hosmer

The executive team at Bioventus has experience in pharmaceutical research and development as well as business development. They have worked at companies such as Anika Therapeutics and Fidia Advanced Biopolymers. They hold degrees in fields such as pharmaceutical chemistry from universities such as the University of Torino.

CEO and Executive Team

Leadership Team

Board of Directors

CEO and Executive Team

About

Team members

Other teams at Bioventus

Leadership Team

Board of Directors